We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2023, which commenced on 3 July 2023. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2023.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 5 changed ingredients is below.
Changed ingredients
|
Substance name |
Change |
|---|---|
|
Refined Buglossoides arvensis seed oil |
Addition |
|
Chicken sternum cartilage powder |
Addition |
|
Change of name from Saccharomyces cervisiae polysaccharides to Saccharomyces cerevisiae polysaccharides |
Change |
|
Violet leaf absolute |
Change |
|
Poloxamine 1301 |
Removal |